Products
Our products
Learn more about our product portfolio and how we’re prioritising vaccines and specialty medicines to get ahead of disease together.
Scroll to explore
Our vaccines and medicines
Getting ahead means preventing disease as well as treating it. Our R&D focus is to deliver new vaccines and medicines using the science of the immune system, human genetics and advanced technologies.
12
vaccines manufacturing sites - enabling a supply capability to produce and deliver 767 million doses in 2021
~ 2m
vaccine doses delivered every day
20+
vaccines, helping to protect lives from diseases including meningitis, shingles, flu, whooping cough, measles, hepatitis and human papillomavirus (HPV)
4 in 10
children receive a GSK vaccine each year
1.7bn
medicine doses produced and delivered in 2021
Explore our innovation stories
Innovation is at the very core of GSK. Discover how we’re uniting science, technology and talent to get ahead of disease together.

Getting ahead of infectious diseases with advanced technology

Digital twin: using advanced technology to accelerate vaccine development

How vaccine science can help tackle antimicrobial resistance

Computational Biology: setting the stage for future wins and new medicines

Could tiny bubbles released from bacteria cells pave the way for new vaccine technology
